Leerink Partners Resumes Acorda Therapeutics, Inc. (ACOR) at Market Perform
- Wall Street again marks new highs in post-election run
- Broadcom Ltd. (AVGO) Tops Q4 EPS by 11c
- Restoration Hardware (RH) Tops Q3 EPS by 4c; Guides Well Below the Street
- Unusual 11 Mid-Day Movers 12/8: (COOL) (TLRD) (DRAM) Higher; (SHIP) (OHRP) (MLSS) Lower
- After-Hours Stock Movers 12/08: (FNSR) (AVGO) (GLPG) Higher; (XTLY) (RH) (DLTH) Lower (more...)
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
Leerink Partners resumes coverage on Acorda Therapeutics, Inc. (NASDAQ: ACOR) with a Market Perform rating and a price target of $25.00.
Analyst Paul Matteis commented, "Acorda is a biotechnology company that is approaching a set of meaningful catalysts that on balance precipitate multiple key strategic decisions for the company in 2017. We are very bullish on CVT-301 in Parkinson's Disease (PD) OFFs; however, based on outstanding formulation risk, IP uncertainty, the small clinical benefit seen in ph2 and the need for large expensive ph3's, we are considerably more cautious on the Ampyra (dalfampridine) once-daily (QD) Stroke program. Meanwhile, based on prior MEDACorp patent key opinion leader (KOL) feedback and what we see as an uphill battle in the IPR/P4 processes, we believe investors should largely assume that generics hit the Ampyra business in 2H18/2019, well ahead of 2025-2027 expiry for 4 method-of-treatment patents."
Shares of Acorda Therapeutics, Inc. closed at $20.83 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMO Capital Cuts Price Target on Comtech Telecom (CMTL) to $16 Following 1Q
- Jefferies Downgrades SL Green Realty (SLG) to Hold
- UPDATE: Stifel Downgrades Timken (TKR) to Hold
Create E-mail Alert Related CategoriesAnalyst Comments, New Coverage
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!